Shenzhen Liying Biotechnology
Specializes in protein design and modification for synthetic biology and biopharmaceutical applications
About Shenzhen Liying Biotechnology
Lybio.com specializes in protein design and modification, offering high-quality and efficient research and development services for a wide range of protein applications. The company synthesizes protein materials and provides tailored solutions for various industries, including pharmaceuticals, biotechnology, and healthcare. The core technology founders and team members boast over a decade of experience from prestigious institutions such as the University of Oxford, the University of Cambridge, and the Francis Crick Institution. Lybio.com serves clients ranging from academic researchers to commercial enterprises, operating in the global biotechnology market. The business model revolves around providing contract research organization (CRO) and contract development and manufacturing organization (CDMO) services, generating revenue through project-based contracts and long-term partnerships.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Open positions
- 1
- Dealroom signal
- 18.7/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, DT and LS, science-based
- Links
- Website
News
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2025 | $14M | $55M | Undisclosed | ↗ |
| SEEDEquity / VC | Nov 2023 | $0 | — | Hina Group | ↗ |
Growth signals
Latest recorded traffic for Shenzhen Liying Biotechnology is 2.5K monthly website visits, down 73.4% over the last three months.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shenzhen Liying Biotechnology in the Shenzhen ecosystem
The Shenzhen Liying Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
- WMWuxi Best Precision Machinery
- SPShenzhen Weiguang Biological Products
- HGHina Group
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Shenzhen Liying Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shenzhen Liying Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







